← Leaderboards
Mark Wunderlich
Cincinnati Childrens Hosp Med Ctr
$1,669,128
Attributed
$1,669,128
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $202K · FY2016–25$250K$187.5K$125K$62.5K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,669,128 · 1
By mechanism
R50$1,669,128 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Paul W. Spearman$26,612,118
- Susanne Irmtraud Wells$12,656,530
- Stephen N. Waggoner$9,481,800
- Sing Sing Way$29,358,207
- Jason T Blackard$10,171,334
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsLeukemiaLoss Of HeterozygosityInsightCell ModelIn VivoHematologic NeoplasmsInstitutionImmunodeficient MouseInbred StrainDetectionDrug DevelopmentDrug DiscoveryCellsEnvironmentAffectHematopoiesisFlow CytometryFundingCarcinogenesis MechanismGene Expression RegulationGeneticGenomicsMolecular
Grant awards (9)
Therapeutic insights through patient derived leukemia xenografts$201,992
R50 · FY2025 · CA · contact PI
Therapeutic insights through patient derived leukemia xenografts$201,992
R50 · FY2024 · CA · contact PI
Therapeutic insights through patient derived leukemia xenografts$201,992
R50 · FY2023 · CA · contact PI
Therapeutic insights through patient derived leukemia xenografts$201,992
R50 · FY2022 · CA · contact PI
Therapeutic insights through patient derived leukemia xenografts$172,232
R50 · FY2020 · CA · contact PI
Therapeutic insights through patient derived leukemia xenografts$172,232
R50 · FY2019 · CA · contact PI
Therapeutic insights through patient derived leukemia xenografts$172,232
R50 · FY2018 · CA · contact PI
Therapeutic insights through patient derived leukemia xenografts$172,232
R50 · FY2017 · CA · contact PI
Therapeutic insights through patient derived leukemia xenografts$172,232
R50 · FY2016 · CA · contact PI